CompoAtlas

Naturella - Capsules Malva-C

Natural health product licensed in Canada

Other names
Naturella - Capsules Malva-C avec Malva sylvestris/feuilles de mauve
Licence holder
J.L. 2000 Inc.
NPN or DIN-HM
80115967
Status
Active licence
Licence date
30 January 2022
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Traditionnelle

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Senna alexandrina

Source : Feuille

250 mgNot calculated
Taraxacum officinale

Source : Taraxacum officinale - Racine

100 mgNot calculated
Malva sylvestris

Source : Feuille

250 mgNot calculated

Non-medicinal ingredients

Hypromellose, Gélatine, Stéarate de magnésium

PopulationAgeQuantity per servingFrequency
Adultesminimum: 18 yearsminimum: 2 Capsule ; maximum: 3 Capsule1 Tous les jours

Uses authorised in Canada

(Utilisée traditionnellement en phytothérapie comme) laxatif stimulant. (Utilisée en phytothérapie pour le) soulagement à court terme de la constipation occasionnelle . (Utilisée en phytothérapie pour) facilite(r) l'évacuation intestinale (en agissant directement sur le gros intestin).

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80115967

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line